Find Clinical Trial

Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice


← Back
Study Phase

Phase 4

Therapeutic Area

Cardiovascular Diseases

IndicationCoronary Artery Disease
SponsorServier Global Medical Affairs
Active substance/
Medical device

IVABRADINE,
S016257

Active Substance CodeS016257
Protocol CodeControl-2
ISRCTN CodeISRCTN30654443
Other Protocol Name :CONTROL-2


Documents and links

Scientific publication READ MORE



Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility